JP2015506705A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015506705A5 JP2015506705A5 JP2014555853A JP2014555853A JP2015506705A5 JP 2015506705 A5 JP2015506705 A5 JP 2015506705A5 JP 2014555853 A JP2014555853 A JP 2014555853A JP 2014555853 A JP2014555853 A JP 2014555853A JP 2015506705 A5 JP2015506705 A5 JP 2015506705A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- residues
- acid sequence
- influenza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 68
- 206010022000 influenza Diseases 0.000 claims description 44
- 101710154606 Hemagglutinin Proteins 0.000 claims description 38
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims description 38
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims description 38
- 101710176177 Protein A56 Proteins 0.000 claims description 38
- 239000000185 hemagglutinin Substances 0.000 claims description 36
- 229920001184 polypeptide Polymers 0.000 claims description 34
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 34
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 34
- 238000006467 substitution reaction Methods 0.000 claims description 18
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 14
- 150000007523 nucleic acids Chemical class 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 102000005348 Neuraminidase Human genes 0.000 claims description 8
- 108010006232 Neuraminidase Proteins 0.000 claims description 8
- 108020004707 nucleic acids Proteins 0.000 claims description 8
- 102000039446 nucleic acids Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108020001507 fusion proteins Proteins 0.000 claims description 6
- 102000037865 fusion proteins Human genes 0.000 claims description 6
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims description 4
- 210000004027 cell Anatomy 0.000 claims description 4
- 241000712461 unidentified influenza virus Species 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 3
- 108020004705 Codon Proteins 0.000 claims description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 230000028993 immune response Effects 0.000 claims description 2
- 230000003053 immunization Effects 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 210000004962 mammalian cell Anatomy 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 238000001890 transfection Methods 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 235000013372 meat Nutrition 0.000 claims 1
- 238000000034 method Methods 0.000 description 6
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261596014P | 2012-02-07 | 2012-02-07 | |
| US61/596,014 | 2012-02-07 | ||
| PCT/US2013/024957 WO2013119683A1 (en) | 2012-02-07 | 2013-02-06 | Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015506705A JP2015506705A (ja) | 2015-03-05 |
| JP2015506705A5 true JP2015506705A5 (enExample) | 2016-03-03 |
| JP6336915B2 JP6336915B2 (ja) | 2018-06-06 |
Family
ID=48947966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014555853A Expired - Fee Related JP6336915B2 (ja) | 2012-02-07 | 2013-02-06 | 計算で最適化した広い反応性を示すh3n2、h2n2、およびb型インフルエンザウイルスの抗原 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9234008B2 (enExample) |
| EP (1) | EP2812348A4 (enExample) |
| JP (1) | JP6336915B2 (enExample) |
| KR (1) | KR20140127827A (enExample) |
| CN (1) | CN104136456A (enExample) |
| AU (2) | AU2013217166B2 (enExample) |
| BR (1) | BR112014018884A2 (enExample) |
| CA (1) | CA2863981A1 (enExample) |
| HK (1) | HK1203524A1 (enExample) |
| IN (1) | IN2014DN05805A (enExample) |
| MX (1) | MX2014009148A (enExample) |
| RU (2) | RU2018113521A (enExample) |
| SG (1) | SG11201404653UA (enExample) |
| WO (1) | WO2013119683A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011302360B2 (en) * | 2010-09-14 | 2015-01-29 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Computationally optimized broadly reactive antigens for influenza |
| JP6113155B2 (ja) | 2011-06-20 | 2017-04-12 | ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 計算で最適化した広い反応性を示すh1n1インフルエンザの抗原 |
| EP3305806B1 (en) | 2012-02-13 | 2020-08-26 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Computationally optimized broadly reactive antigens for human and avian h5n1 influenza |
| CA2868330A1 (en) | 2012-03-30 | 2013-10-03 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses |
| SG11201503989PA (en) | 2012-11-27 | 2015-06-29 | Univ Pittsburgh | Computationally optimized broadly reactive antigens for h1n1 influenza |
| CN107847579A (zh) * | 2014-12-19 | 2018-03-27 | 俄勒冈健康与科学大学 | 人和禽h5n1流感的计算优化的广泛反应性抗原的协同共同给药 |
| CA2987939A1 (en) | 2015-06-02 | 2016-12-08 | Sanofi Pasteur Inc. | Engineered influenza antigenic polypeptides and immunogenic compositions thereof |
| CA2986701A1 (en) | 2015-06-09 | 2016-12-15 | Sanofi Pasteur, Inc. | Methods of optimizing nucleotide sequences encoding engineered influenza proteins |
| US10485864B2 (en) | 2015-09-21 | 2019-11-26 | Oregon Health & Science University | Characterization of influenza vaccines |
| EP3464328A1 (en) * | 2016-06-02 | 2019-04-10 | Sanofi Pasteur Inc. | Engineered influenza antigenic polypeptides and immunogenic compositions thereof |
| KR102731582B1 (ko) | 2016-06-03 | 2024-11-15 | 사노피 파스퇴르 인코포레이티드 | 조작된 인플루엔자 헤마글루티닌 폴리펩티드의 변형 |
| US20210225457A1 (en) * | 2018-07-13 | 2021-07-22 | University Of Georgia Research Foundation | Methods for generating pan-epitopic immunogens of influenza h3 virus, compositions and methods of use thereof |
| WO2020065349A2 (en) * | 2018-09-28 | 2020-04-02 | The Chancellor, Masters And Scholars Of The University Of Cambridge | Vaccines and methods |
| WO2024167855A1 (en) * | 2023-02-06 | 2024-08-15 | Emergent Product Development Gaithersburg Inc. | Influenza hemagglutinin constructs and compositions |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5662907A (en) | 1992-08-07 | 1997-09-02 | Cytel Corporation | Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| EP0772619B2 (en) | 1994-07-15 | 2010-12-08 | The University of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| AU738513B2 (en) | 1997-02-28 | 2001-09-20 | University Of Iowa Research Foundation, The | Use of nucleic acids containing unmethylated CpG dinucleotide in the treatment of LPS-associated disorders |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| DE69838294T2 (de) | 1997-05-20 | 2009-08-13 | Ottawa Health Research Institute, Ottawa | Verfahren zur Herstellung von Nukleinsäurekonstrukten |
| ES2284247T3 (es) | 1998-04-03 | 2007-11-01 | University Of Iowa Research Foundation | Metodos y productos para estimular el sistema inmunitario usando oligonucleotidos y citoquinas inmunoterapeuticos. |
| CN1311871C (zh) | 2000-03-02 | 2007-04-25 | 爱莫里大学 | Dna表达载体及其应用方法 |
| US20050181459A1 (en) | 2002-06-11 | 2005-08-18 | Matthew Baker | Method for mapping and eliminating T cell epitopes |
| CA2816222A1 (en) * | 2003-06-16 | 2005-03-03 | Medimmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase variants |
| US8592197B2 (en) | 2003-07-11 | 2013-11-26 | Novavax, Inc. | Functional influenza virus-like particles (VLPs) |
| CN101163714A (zh) | 2005-02-24 | 2008-04-16 | 马萨诸塞大学 | 流感病毒核酸、多肽及其用途 |
| WO2007072214A2 (en) | 2005-12-19 | 2007-06-28 | Novartis Vaccines And Diagnostics Srl | Methods of clustering gene and protein sequences |
| US20080045472A1 (en) | 2006-03-31 | 2008-02-21 | Council Of Scientific And Industrial Research Bharat Biotech | Targets for human micro rnas in avian influenza virus (h5n1) genome |
| WO2007130327A2 (en) | 2006-05-01 | 2007-11-15 | Technovax, Inc. | Influenza virus-like particle (vlp) compositions |
| WO2007134327A2 (en) * | 2006-05-15 | 2007-11-22 | Sea Lane Biotechnologies, Llc. | Neutralizing antibodies to influenza viruses |
| US8980281B2 (en) | 2006-09-05 | 2015-03-17 | Academia Sinica | High-yield transgenic mammalian expression system for generating virus-like particles |
| MY170607A (en) | 2006-09-07 | 2019-08-20 | Crucell Holland Bv | Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| EP2061887B1 (en) | 2006-10-04 | 2018-01-24 | The University Of Queensland | Vlp based influenza vaccine delivery system |
| WO2008145129A2 (en) * | 2007-05-31 | 2008-12-04 | Statens Serum Institut | Influenza vaccines |
| CA2615372A1 (en) | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Influenza virus-like particles (vlps) comprising hemagglutinin |
| EP2185195A2 (en) | 2007-08-16 | 2010-05-19 | Tripep Ab | Immunogen platform |
| AU2008331673B2 (en) * | 2007-11-12 | 2014-12-11 | The Trustees Of The University Of Pennsylvania | Novel vaccines against multiple subtypes of influenza virus |
| KR101956910B1 (ko) * | 2008-01-21 | 2019-03-12 | 메디카고 인코포레이티드 | 헤마글루티닌을 발현하는 트랜스제닉 식물에서 생산된 재조합 인플루엔자 바이러스-유사 입자(VLPs) |
| US7981428B2 (en) | 2008-01-23 | 2011-07-19 | Academia Sinica | Flu vaccines and methods of use thereof |
| WO2010036970A2 (en) | 2008-09-25 | 2010-04-01 | Fraunhofer Usa, Inc. | Influenza vaccines, antigens, compositions, and methods |
| US20110177122A1 (en) | 2008-09-26 | 2011-07-21 | The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services | Dna prime/activated vaccine boost immunization to influenza virus |
| JP5797636B2 (ja) | 2009-04-03 | 2015-10-21 | メリアル リミテッド | ニューカッスル病ウイルスをベクターとするトリワクチン |
| WO2011087839A1 (en) * | 2009-12-22 | 2011-07-21 | Baxter International Inc. | Vaccine to influenza a virus |
| US8298820B2 (en) * | 2010-01-26 | 2012-10-30 | The Trustees Of The University Of Pennsylvania | Influenza nucleic acid molecules and vaccines made therefrom |
| AU2011302360B2 (en) | 2010-09-14 | 2015-01-29 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Computationally optimized broadly reactive antigens for influenza |
| JP6113155B2 (ja) | 2011-06-20 | 2017-04-12 | ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 計算で最適化した広い反応性を示すh1n1インフルエンザの抗原 |
-
2013
- 2013-02-06 RU RU2018113521A patent/RU2018113521A/ru not_active Application Discontinuation
- 2013-02-06 EP EP13747212.2A patent/EP2812348A4/en not_active Withdrawn
- 2013-02-06 RU RU2014135703A patent/RU2653756C2/ru not_active IP Right Cessation
- 2013-02-06 BR BR112014018884A patent/BR112014018884A2/pt not_active IP Right Cessation
- 2013-02-06 SG SG11201404653UA patent/SG11201404653UA/en unknown
- 2013-02-06 KR KR1020147023368A patent/KR20140127827A/ko not_active Withdrawn
- 2013-02-06 CA CA2863981A patent/CA2863981A1/en not_active Abandoned
- 2013-02-06 MX MX2014009148A patent/MX2014009148A/es unknown
- 2013-02-06 WO PCT/US2013/024957 patent/WO2013119683A1/en not_active Ceased
- 2013-02-06 US US14/376,689 patent/US9234008B2/en active Active
- 2013-02-06 AU AU2013217166A patent/AU2013217166B2/en not_active Ceased
- 2013-02-06 IN IN5805DEN2014 patent/IN2014DN05805A/en unknown
- 2013-02-06 HK HK15104019.2A patent/HK1203524A1/xx unknown
- 2013-02-06 CN CN201380008469.3A patent/CN104136456A/zh active Pending
- 2013-02-06 JP JP2014555853A patent/JP6336915B2/ja not_active Expired - Fee Related
-
2017
- 2017-06-29 AU AU2017204454A patent/AU2017204454A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015506705A5 (enExample) | ||
| RU2014101401A (ru) | Антигены вируса гриппа h1n1 с широким спектром активности, оптимизированные с применением вычислительных средств | |
| RU2018113521A (ru) | Рекомбинантный полипептид гемагглютинин (ha) вируса гриппа для вызова иммунного ответа в отношении вирусов гриппа h2n2 или b | |
| RU2017141447A (ru) | Рекомбинантные полипептиды гемагглютинина (ha) вируса гриппа, композиции, содержащие их, и способы вызова иммунного ответа в отношении вируса гриппа h1n1 | |
| JP6655623B2 (ja) | 新規多価ナノ粒子に基づくワクチン | |
| JP2016505538A5 (enExample) | ||
| WO2020234300A1 (en) | A subunit vaccine for treatment or prevention of a respiratory tract infection | |
| JP2014530010A5 (enExample) | ||
| JP2009544318A5 (enExample) | ||
| RU2019139064A (ru) | Композиции и способы для лечения цитомегаловируса | |
| JP2012095652A5 (enExample) | ||
| JP2015501840A5 (enExample) | ||
| JP2014502156A5 (enExample) | ||
| JP2012511579A5 (enExample) | ||
| JP2010535026A5 (enExample) | ||
| JP2015505299A5 (enExample) | ||
| JP2014507146A5 (enExample) | ||
| JP2015524422A5 (enExample) | ||
| JP2014519817A5 (enExample) | ||
| RU2015124805A (ru) | Оптимизированные с помощью вычислительных средств антигены с широким спектром реактивности для вируса гриппа h1n1 | |
| JP2015521206A5 (enExample) | ||
| JP2019500320A5 (enExample) | ||
| WO2022020460A1 (en) | Vaccine using m2/bm2-deficient influenza vectors | |
| JP5560510B2 (ja) | カプシドタンパク質及びその利用 | |
| Liu et al. | A self-assembling nanoparticle: Implications for the development of thermostable vaccine candidates |